GL1X · GenesisL1 explorer

MolNFT v1 · #139334 · protein

Crystal structure of human K-RAS G12D mutant in complex with GDP and cyclic inhibitory peptide

5XCO · GTPase KRAS: “Crystal structure of human K-RAS G12D mutant in complex with GDP and cyclic inhibitory peptide”. X-ray diffraction, 3 ligands (ACE, GDP, NH2), 2 pockets (best druggability 0.45). MolNFT v1 #139334 on GenesisL1: 3D…

PDB
5XCO
Type
protein
Length
189 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS; ACE-arg-arg-arg-arg-cys-pro-leu-tyr-ile-ser-tyr-asp-pro…
UniProt
P01116
Ligands
ACE, GDP, NH2
Pockets
2 · best druggability 0.45

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGTPase KRASprotein17037% helix, 25% strandP01116
BACE-arg-arg-arg-arg-cys-pro-leu-tyr-ile-ser-tyr-asp-pro- val-cys-arg-arg-arg-arg-NH2protein1921% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B
  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • NH2 · Amino group · ion · chains B
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11630.450.7529GDP
21230.420.7620empty

Interfaces

1 interface between chains.

  • A–B · 719 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 5XCO · Crystal structure of human K-Ras G12D Mutant in complex with GDP and Cyclic Inhibitory… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.